Dan Ripley is the Senior Director of Business Development. Mr. Ripley joined Kalypsys in March, 2006 with over 20 years of integrated business and science management experience. Prior to joining Kalypsys, Mr. Ripley was Director of Business Development for five years at Isis Pharmaceuticals. He was responsible for new business development including drug licensing, technology licensing, drug discovery collaborations, and patent enforcement. Mr. Ripley has structured and negotiated drug licenses, technology licenses and research and development partnerships with leading pharmaceutical and biotechnology companies including Pfizer, Amgen, Chiron, Alnylam, GlaxoSmithKline, Johnson & Johnson, Dupont, NIH, Cold Spring Harbor, OncoGenex and others. He previously held business development, purchasing management and scientific management positions during his twelve years at The Immune Response Corporation. He received a B.S. in Microbiology and an M.B.A. in Finance from San Diego State University.